Brian Peterson's questions to Doximity Inc (DOCS) leadership • Q1 2026
Question
Brian Peterson of Raymond James asked about the long-term opportunity for Doximity's new AI products like Scribe and Pathway, and sought clarification on the implied revenue deceleration in the second-half guidance.
Answer
Co-Founder and CEO Jeff Tangney positioned the AI suite as Doximity's "third act," with potential as large as their newsfeed and workflow tools by addressing core clinical questions at the point of care. CFO Anna Bryson explained the cautious second-half outlook is due to not extrapolating Q1's outperformance, their smallest bookings quarter, amid ongoing policy uncertainty, despite not yet seeing any business slowdown.